ditor's note: Recently, Suzhou Ruiqian Medical Technology Co., Ltd. (referred to as "Ruiqian Medical") announced that it has been awarded the Suzhou Mint Angel Fund and Guoqian Venture Capital Management (Suzhou) Co., Ltd. (referred to as "Guqian Venture Capital"). Ten million yuan Pre-A round of financing.E
Ruiqian Medical was founded on July 31, 2017 by Dr. Wu Xiangchen, a national “Thousand Talents Plan” expert in the field of R & D of intelligent cytology solutions and high-precision testing equipment, and two other “Thousand Talent Plan” experts. High-tech company specializing in digital pathology and AI pathology-assisted diagnosis technology.
Based on ultra-high-speed 3D microscopy and AI technology with independent intellectual property rights, Ruiqin has entered the larger clinical monomer testing market of cervical cancer screening with cervical cancer thin-layer liquid-based cytology as the entry point. The system can realize high-speed, standardized data import and quickly identify image data, assist doctors to complete diagnosis efficiently and with high quality. In the future, it will provide pathology departments with complete intelligent pathology solutions based on the advantages of platform technology, and promote the innovation and innovation of Chinese pathology. development of.
One of the company's founders: Dr. Wu Xiangchen
Dr. Wu Xiangchen, founder and general manager of Ruiqian Medical, said that after the intensive research and development of the entrepreneurial team, artificial intelligence + digital pathology big data has begun to have the feasibility of industrialization. This is the starting point of the team's entrepreneurship. Compared with the current manual diagnosis, the intelligent cancer cell detection system based on microscopic digital pathology can realize high-speed scanning and identification, greatly improve the detection efficiency, reduce the missed detection rate, and provide better for pathological prevention and treatment of cervical cancer, especially for women s method.
Founder of Mint Fund: Ms. Liu Yuwen
Ms. Liu Yuwen, founding partner of Suzhou Mint Angel Fund, said: As a "gold standard" for disease diagnosis and a reliable basis for guiding clinical and prognosis, pathological diagnosis is given a more accurate, faster and smarter mission in the medical era. As a technology-driven early-stage fund, Mint Angel Fund is committed to finding innovative technical solutions to address unmet clinical needs. Intelligent pathological diagnosis is an area that Mint continues to look forward to and focuses on. I am very happy to work with the Ruiqian team to jointly explore new technologies in the early screening of cervical cancer.
Chairman of Guoqian Venture Capital: Dr. Zhang Xu
Zhang Xu, Chairman of Guoqian Venture Capital, said: Qianqian Medical was introduced by Guoqian in 2017 and landed in Suzhou High-tech Zone. I am very pleased to see that I have won the "Gusu Innovation and Entrepreneurship Leadership Talent" within more than one year "," Science and Technology Leading Talents in High-tech Zone "," Double Talents in Jiangsu Province "and other honors. Ruiqian Medical is unique in terms of hardware platform, artificial intelligence algorithms and big data. In the future, Ruiqian Medical will gradually expand to the intelligent pathology detection of other cancer types according to the technology maturity, and contribute to the intelligent vision of the Chinese Pathology Department.
Guoqian Venture Capital Management (Suzhou) Co., Ltd.
Guoqian Venture Capital was jointly established by Dr. Zhang Xu and other six national "Thousand Talents Plan" experts in the medical device related field, and the Suzhou Medical Institute of the Chinese Academy of Sciences and other shareholders.
Based on the business philosophy of "achieving the dreams of others", Guoqian Medical takes the national "Thousand Talents Plan" experts and its radiating high-end scientific and technological talents as the core, and takes medical devices, in vitro diagnostic reagents, medical services and other main fields as its talent projects In the process of introduction, innovation and entrepreneurship project evaluation, and the transformation of scientific and technological achievements, high-quality entrepreneurial projects are sought. The value of the project is discovered and the project is discovered through private equity investment, talent project introduction and service, entrepreneurial project acceleration and empowerment, industrial investment and integration. Value, build a cluster and ecosystem of medical and health industries.